SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (74)7/18/2000 1:09:03 PM
From: scaram(o)uche   of 724
 
more genomics "trickle down" coming... deCode raises $170 million...... more shakers, more incubators, more ultralow freezers....... a smart suitor could do quite nicely, offering a 100% premium for just the core NBSC business, IMO........

Tuesday July 18, 12:23 pm Eastern Time

U.S. investors warm up to Iceland's DeCode IPO

NEW YORK, July 18 (Reuters) - Investors warmed up to the initial public offering of
DeCode Genetics Inc. (NasdaqNM:DCGN - news) , a controversial company aiming to
study Iceland's unique genetic heritage, and pushed its shares more than 55 percent higher
on Tuesday.

Stock of the Reykjavik, Iceland-based firm, which will begin trading on Europe's Easdaq on
Wednesday, gained $10 to $28 on the U.S.'s tech-rich Nasdaq. DeCode Genetics raised
$172.8 million by pricing its shares at $18 each, the top of the expected $14-$18 price range. (snip)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext